Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients

Cervical cancer (CC) is the fourth leading cause of cancer death (~ 324,000 deaths annually) among women internationally, with 85% of these deaths reported in developing regions, particularly sub-Saharan Africa and Southeast Asia. Human papillomavirus (HPV) is considered the major driver of CC, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Soumik, Babu, Achsha, Medha, Tamma, Ramanathan, Gnanasambandan, Mukherjee, Anirban Goutam, Wanjari, Uddesh Ramesh, Murali, Reshma, Kannampuzha, Sandra, Gopalakrishnan, Abilash Valsala, Renu, Kaviyarasi, Sinha, Debottam, George Priya Doss, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105157/
https://www.ncbi.nlm.nih.gov/pubmed/37060468
http://dx.doi.org/10.1007/s12032-023-01997-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105157/
https://www.ncbi.nlm.nih.gov/pubmed/37060468
http://dx.doi.org/10.1007/s12032-023-01997-9

Ejemplares similares